GB9027211D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9027211D0
GB9027211D0 GB909027211A GB9027211A GB9027211D0 GB 9027211 D0 GB9027211 D0 GB 9027211D0 GB 909027211 A GB909027211 A GB 909027211A GB 9027211 A GB9027211 A GB 9027211A GB 9027211 D0 GB9027211 D0 GB 9027211D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909027211A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB909027211A priority Critical patent/GB9027211D0/en
Publication of GB9027211D0 publication Critical patent/GB9027211D0/en
Priority to PCT/GB1991/002221 priority patent/WO1992010183A1/en
Priority to JP4501728A priority patent/JPH06503335A/en
Priority to AU90649/91A priority patent/AU9064991A/en
Priority to EP92900718A priority patent/EP0561901A1/en
Priority to US09/929,814 priority patent/US20020128300A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB909027211A 1990-12-14 1990-12-14 Medicaments Pending GB9027211D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB909027211A GB9027211D0 (en) 1990-12-14 1990-12-14 Medicaments
PCT/GB1991/002221 WO1992010183A1 (en) 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
JP4501728A JPH06503335A (en) 1990-12-14 1991-12-12 Use of angiotensin 2 receptor antagonists in the treatment of diabetic retinopathy
AU90649/91A AU9064991A (en) 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
EP92900718A EP0561901A1 (en) 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
US09/929,814 US20020128300A1 (en) 1990-12-14 2001-08-14 Medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027211A GB9027211D0 (en) 1990-12-14 1990-12-14 Medicaments

Publications (1)

Publication Number Publication Date
GB9027211D0 true GB9027211D0 (en) 1991-02-06

Family

ID=10687045

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909027211A Pending GB9027211D0 (en) 1990-12-14 1990-12-14 Medicaments

Country Status (5)

Country Link
EP (1) EP0561901A1 (en)
JP (1) JPH06503335A (en)
AU (1) AU9064991A (en)
GB (1) GB9027211D0 (en)
WO (1) WO1992010183A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB9208116D0 (en) 1992-04-13 1992-05-27 Ici Plc Therapeutic agents
NZ251741A (en) * 1992-04-13 1997-06-24 Zeneca Ltd Use of angiotensin ii antagonists for treating disease conditions associated with impaired neuronal conduction velocity
MX9603259A (en) * 1994-02-08 1997-03-29 Novartis Ag Treatment of normotensive glaucoma with angiotensin ii antagonists.
US5658734A (en) * 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
KR20010074838A (en) * 1998-08-20 2001-08-09 요시다 쇼지 Preventives or remedies for eye circulatory failure
CZ301913B6 (en) * 1999-04-28 2010-07-28 Takeda Pharmaceutical Company Limited Pharmaceutical composition for prevention, treatment or inhibition of development of simple retinopathy or pre-proliferative retinopathy
US6800439B1 (en) 2000-01-06 2004-10-05 Affymetrix, Inc. Methods for improved array preparation
US6806361B1 (en) 2000-03-17 2004-10-19 Affymetrix, Inc. Methods of enhancing functional performance of nucleic acid arrays
US6833450B1 (en) 2000-03-17 2004-12-21 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
US7005259B1 (en) 2000-06-01 2006-02-28 Affymetrix, Inc. Methods for array preparation using substrate rotation
US6596490B2 (en) 2000-07-14 2003-07-22 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US6380377B1 (en) * 2000-07-14 2002-04-30 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
EP1752450A1 (en) 2005-08-01 2007-02-14 Merck Sante Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (en) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
EP0955294B1 (en) * 1989-06-14 2003-09-24 Smithkline Beecham Corporation Imidazolyl-alkenoic acid
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
JPH05507469A (en) 1990-04-13 1993-10-28 スミスクライン・ビーチャム・コーポレイション Substituted benzimidazoles

Also Published As

Publication number Publication date
AU9064991A (en) 1992-07-08
JPH06503335A (en) 1994-04-14
WO1992010183A1 (en) 1992-06-25
EP0561901A1 (en) 1993-09-29

Similar Documents

Publication Publication Date Title
ZA919750B (en) Medicaments
GB9012469D0 (en) Medicaments
AP9200461A0 (en) Medicaments
AP9200403A0 (en) Medicaments
GB9027211D0 (en) Medicaments
GB9027210D0 (en) Medicaments
GB9027200D0 (en) Medicaments
GB9027208D0 (en) Medicaments
GB9027212D0 (en) Medicaments
GB9027199D0 (en) Medicaments
GB9027198D0 (en) Medicaments
GB9027197D0 (en) Medicaments
GB9027209D0 (en) Medicaments
GB9027201D0 (en) Medicaments
GB9104650D0 (en) Medicaments
GB9108348D0 (en) Medicaments
GB9016612D0 (en) Medicaments
GB9011940D0 (en) Medicaments
GB9013265D0 (en) Medicaments
GB9022016D0 (en) Medicaments
GB9024368D0 (en) Medicaments
GB9010366D0 (en) Medicaments
GB9009067D0 (en) Medicaments
GB9004044D0 (en) Medicaments
GB9004015D0 (en) Medicaments